FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Glenmark Pharmaceuticals Azelaic Acid Gel Recall

Azelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Gl…

Glenmark Pharmaceuticals Inc., USA · Elmwood Park, NJ

Risk level
Class II
Reported by FDA
Aug 5, 2026
Recall ID
D-0731-2026
Check your lot numberHow we source this data

Summary

Glenmark Pharmaceuticals recalled Azelaic Acid Gel starting Jul 23, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0731-2026 on Aug 5, 2026. Reason: CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received. Status: Ongoing.

Why it was recalled

CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.

Product description

Azelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ 07407, NDC 68462-626-52.

Lot numbers, UPCs & expiration codes

Lot #: 19260937A, Exp. Date February 2028; 19261225A, 19261185A, Exp. Date March 2028; 19261664A, 19261682A, Exp. Date April 2028.

Where it was sold

Nationwide within the United States.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0731-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jul 23, 2026
FDA report date
Aug 5, 2026
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Glenmark Pharmaceuticals Inc., USA

Original FDA data

Every field from FDA enforcement report D-0731-2026, exactly as published.

Show all FDA fields
City
Elmwood Park
State
NJ
Status
Ongoing
Country
United States
Event ID
99490
Address
619 River Dr
Code information
Lot #: 19260937A, Exp. Date February 2028; 19261225A, 19261185A, Exp. Date March 2028; 19261664A, 19261682A, Exp. Date April 2028.
Postal code
07407-1317
Report date
Aug 5, 2026
Product type
Drugs
Recall number
D-0731-2026
Classification
Class II
Recalling firm
Glenmark Pharmaceuticals Inc., USA
Reason for recall
CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Azelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ 07407, NDC 68462-626-52.
Distribution pattern
Nationwide within the United States.
Recall initiation date
Jul 23, 2026
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Jul 28, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0731-2026, published Aug 5, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls